Rising Prevalence Of Pcos Fuels Demand For Iron Deficiency Injectables: Transformative Forces Shaping the Iron Deficiency Injectable Market Landscape in 2025

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Will the Iron Deficiency Injectable Industry Market Size Be by 2025?
In recent years, there has been significant growth in the market size of iron deficiency injectables. The market is predicted to escalate from $14.06 billion in 2024 to $15.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The historical growth is largely due to the high frequency of iron deficiency anemia treatments, the increasing number of patients undergoing bariatric surgery, and the rise in pediatric, adolescent, and pregnant patients.

What's the Long-Term Growth Forecast for the Iron Deficiency Injectable Market Size Through 2029?
Anticipations for swift expansion are looming over the iron deficiency injectable market in the approaching years. The market worth is speculated to be $23.13 billion in 2029, with a compound annual growth rate (CAGR) of 10.8%. The remarkable growth in the predicted duration can be credited to factors like the elderly demographic, global health drives, government schemes, an upsurge in treatments for enduring ailments, and quick iron restock. Major advancements expected during this duration involve improved iron treatments, digital health innovations, developments in iron deficiency injectable procedures, and the use of iron-founded drugs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

What Are the Key Growth Drivers Fueling the Iron Deficiency Injectable Market Expansion?
The uptick of polycystic ovar*y syndrome (PCOS)-a commonplace hormonal disorder primarily affecting female individuals of reproductive age- is poised to pace the expansion of the iron deficiency injectables market. PCOS often results in iron overload, triggering excessive blood loss during menstruatio*n cycles and leading to anemia. This condition is treatable using injectable iron deficiency drugs. The World Health Organization reported in June 2023 that 8-13% of women of reproductive age worldwide are affected by PCOS, with 70% of these cases undiagnosed. As such, the spread of PCOS will likely facilitate the growth of the iron deficiency injectables market. Iron Deficiency Injectable Market Driver: Surge in Malnutrition Incidence Stimulates the Iron Deficiency Injectable Market's Growth

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

What Are the Key Trends Driving Iron Deficiency Injectable Market Growth?
Major companies in the iron deficiency injectables market, like INJECTAFER, are introducing new therapies to maintain their market standing. For example, in June 2023, Daiichi Sankyo Company, a healthcare corporation based in the US, and American Regent Inc., a US producer of injectables, introduced INJECTAFER (ferric carboxymaltose injection) to treat iron deficiencies. This product, approved by the Food And Drug Administration, a US governmental agency, is the first and only intravenous iron substitute therapy to receive FDA agreement for adult patients suffering from recurrent and progressive heart failure. INJECTAFER underwent over 40 clinical trials with more than 8,800 participants worldwide. This new approval highlights INJECTAFER's established and successful application in patients, including adults and children suffering from iron-deficient anemia and heart failure.

How Is the Iron Deficiency Injectable Market Segmented?
The iron deficiency injectable market covered in this report is segmented -

1) By Type: Iron Dextran, Iron Sucrose, Ferric Carboxymaltose
2) By Branded or Generics: Branded, Generics
3) By Application: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Iron Dextran: Low Molecular Weight Iron Dextran, High Molecular Weight Iron Dextran
2) By Iron Sucrose: Venofer
3) By Ferric Carboxymaltose: Injectafer, Ferinject

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

Which Companies Are Leading the Charge in Iron Deficiency Injectable Market Innovation?
Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

Which Regions Are Leading the Global Iron Deficiency Injectable Market in Revenue?
North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12907

""This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."""

Contact Us:
The Business Research Company
Europe: +44 7882 955267
Asia: +91 88972 63534
Americas: +1 310-496-7795
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.